Simvastatin Therapy in Women With Polycystic Ovary Syndrome.
The purpose of this study is to determine whether statins (simvastatin) improve clinical (excessive hair, skin problems), endocrine (androgens) and metabolic (lipids, markers of systemic inflammation) in women with polycystic ovary syndrome (PCOS).
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Effects of Simvastatin on Clinical, Endocrine, Metabolic and Biochemical Parameters of Women With Polycystic Ovary Syndrome: Prospective, Randomized Trial.|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00365638
|Division of Infertility and Reproductive Endocrinology, Department of Gynecology and Obsterics|
|Poznan, Poland, 60-184|
|Principal Investigator:||Leszek Pawelczyk, MD PhD||Poznan University of Medical Sciences|
|Study Director:||Antoni J Duleba, MD||Yale University|